Search clinical trials for: poor risk

Total 16847 results

University of Rome G. Marconi
University of Bologna; University of the Italian Switzerland

Not yet recruiting

Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health (MOTHERS)

Stress | Insomnia | Postpartum Depression

Italy
Assiut University

Not yet recruiting

Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children

Portal Vein Thrombosis
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Fondation...

Recruiting

Circadian Rhythm and Other Factors in Memory Clinic Patients (CIRCAME)

Dementia

France
European Foundation for Study of Chronic Liver...

Not yet recruiting

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). (COMBAT)

Liver Cirrhosis
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors (VAPOR)

Non-Seminomatous Germ Cell Tumor

France
American College of Radiology
RTOG Foundation

Not yet recruiting

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx
Malmö University
Malmö City

Recruiting

PROSENIOR. Prevention of Pressure Ulcers, Malnutrition, Poor Oral Health and Falls Among Older Persons Receiving Municipal Health Care and Are Registered in the Quality Registry Senior Alert

Malnutrition | Fall | Pressure Ulcer | Oral Health

Sweden
Queen's University, Belfast
University College Dublin; Wageningen University; Dublin City University; Friedrich-Alexander-Universität...

Recruiting

The PROtein Enriched MEDiterranean Diet and EXercise Trial for Older Adults at Risk of Undernutrition (PROMED-EX)

Cognitive Impairment | Cognitive Decline | Poor Nutrition

United Kingdom
Nanfang Hospital of Southern Medical University
Zhujiang Hospital; Huizhou Municipal Central Hospital; Shenzhen University General... and other collaborators

Recruiting

Dynamic Changes of the Human Microbiome Predict the Risk of Poor Prognosis in Patients With Acute Ischemic Stroke: a Multi-center Study

Acute Ischemic Stroke

China
VA Office of Research and Development

Recruiting

A Novel Cognitive Remediation Intervention Targeting Poor Decision-making and Depression in Veterans at High Risk for Suicide: A Safe, Telehealth Approach During the COVID-19 Pandemic (CogRemVet)

Major Depressive Disorder

United States
Istituto Ortopedico Rizzoli

Recruiting

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse (Metform-Bone)

Osteosarcoma | Ewing Sarcoma

Italy
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Seagen Inc.

Recruiting

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditions

United States, Canada, Puerto Rico
Rush University Medical Center
AstraZeneca

Recruiting

Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC (ESR1814205)

Stage III Non-small-cell Lung Cancer

United States
Canadian Cancer Trials Group
Alliance for Clinical Trials in Oncology; NRG Oncology; Eastern Cooperative Oncology... and other collaborators

Recruiting

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)

Breast Cancer

United States, Canada
Monash University

Recruiting

The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health

Cardiovascular Risk Factors | Cognitive Function 1, Social | Poor Glycemic Control

Australia
University of Sydney
Dana-Farber Cancer Institute; University of Southern California; Cambridge University... and other collaborators

Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)

Germ Cell Tumor

Australia, New Zealand, United States
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Terminated

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction (VERITAS)

Very High Risk Neuroblastoma

Italy, Austria, France, Netherlands, Spain
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI); Haitian Group for the Study...

Active, not recruiting

A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

Myocardial Infarction | Heart Failure | Smoking | Stroke | Kidney Diseases | Inflammation | Hypertension | Obesity | Diabetes | Dyslipidemias | Alcohol Use, Unspecified | Cardiac Death | Physical Inactivity | Poor Diet

Haiti
National Cancer Institute (NCI)

Active, not recruiting

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia

United States
University of Waterloo
Canadian Institutes of Health Research (CIHR)

Enrolling by invitation

Extending the Validation of SCREEN to Persons Living With Dementia or in Retirement Homes (SCREEN)

Malnutrition | Dementia | Nutrition Poor

Canada
Keimyung University Dongsan Medical Center

Completed

Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring

Hepatocellular Carcinoma | Portal Vein Thrombosis | Prognosis

Korea, Republic of
Zealand University Hospital

Completed

Risk Factors for Poor Outcome After Epigastric and Umbilical Hernia Repair

Umbilical Hernia | Epigastric Hernia

Denmark
Memorial Sloan Kettering Cancer Center
Mayo Clinic; University of Chicago; University of Pittsburgh; University of Southern... and other collaborators

Active, not recruiting

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Germ Cell Tumors

United States
University of California, Merced
National Cancer Institute (NCI)

Completed

Culturally Appropriate Nutrition Communication for Mexican American Women

Obesity | Chronic Disease | Cancer, Breast | Nutrition Poor | Lifestyle Risk Reduction

United States
Pfizer

Withdrawn

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 (EPIC-HOS)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Immunocompromised | Hospitalization | Child, Hospitalized

United States, Bulgaria
University Hospitals Bristol and Weston NHS Foundation...
University of Bristol

Completed

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth (CoolXenon3)

Hypoxic Ischaemic Encephalopathy

United Kingdom
University Hospitals Bristol and Weston NHS Foundation...
University of Bristol

Completed

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth (CoolXenon2)

Hypoxic Ischaemic Encephalopathy

United Kingdom
New York Medical College
St. Baldrick's Foundation

Active, not recruiting

Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients

Hodgkin Lymphoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
H. Lee Moffitt Cancer Center and Research Institute
Karyopharm Therapeutics Inc

Completed

A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML

Acute Myeloid Leukemia | Leukemia | AML

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

Hypertension | Sleep | Prehypertension | Endothelial Dysfunction | Overweight and Obesity | Vascular Stiffness | Elevated Blood Pressure

United States
University Hospital, Caen

Completed

Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause. (LOCAPORT)

Portal Vein Thrombosis | Local Cause

France
The Netherlands Cancer Institute

Completed

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (OSTRICh)

Metastasis | Prostate Cancer Metastatic

Netherlands
German CLL Study Group
Hoffmann-La Roche

Terminated

Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation (CLLTX1)

Chronic Lymphocytic Leukemia | Richter's Transformation

Germany
Yale University
Pfizer

Terminated

GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia

ACUTE MYELOID LEUKEMIA

United States
M.D. Anderson Cancer Center
Novartis

Completed

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
Peking University People's Hospital

Active, not recruiting

Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

Stem Cell Transplant Complications

China
Celgene

Completed

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

Diffuse B-Cell Lymphoma

Canada, Spain, Belgium, United States
Groupe Hospitalier Paris Saint Joseph

Withdrawn

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome (OUTCOV)

COVID
National Cancer Institute, Naples

Completed

Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer (BRANCH)

Rectal Cancer
Jules Bordet Institute
Université Libre de Bruxelles; Fondation Kisane; Les Amis de l'Institut

Unknown

A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting (MADESIO)

Adults | Hematological Malignancy | Oral Antineoplastic Agents

Belgium
M.D. Anderson Cancer Center

Completed

High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma

Myeloma

United States
Radboud University Medical Center

Completed

10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1

Acute Myeloid Leukemia (AML)

Netherlands, Belgium
Ohio State University Comprehensive Cancer Center

Completed

Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States
VA Connecticut Healthcare System

Unknown

Polyethylene Glycol Cleansing in Patients at High Risk for Poor Bowel Preparation

Colonoscopy

United States
Washington University School of Medicine

Completed

High Risk Youth With Poorly-controlled Diabetes

Type 1 Diabetes Mellitus

United States
Eisai Inc.

Completed

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Poland, Australia, Spain, France, Canada, Mexico, Romania, Taiwan, Russian Federation, Hungary, Serbia, Croatia, United Kingdom, Czechia
Duke University

Completed

A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma

High Risk Melanoma

United States
Hospital Universitario de Canarias

Unknown

Risk Factors of Poor Bowel Cleansing in Inpatients

Colon Adenoma

Search clinical trials for: poor risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations